Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

DEVATIS PTY LTD

Home Clinical Trial Sponsors and OrganizationsDEVATIS PTY LTD

DEVATIS PTY LTD

Docklands, Victoria, Australia

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

0

0 active

Approvals

8

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

TGA

Therapeutic Goods Administration

8

Approvals

Recent Approvals

FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.25 mg capsule blister pack (458465)

FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.25 mg capsule blister pack (458465)

FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.5 mg capsule blister pack (458466)

FINGOLIMOD DEVATIS fingolimod (as hydrochloride) 0.5 mg capsule blister pack (458466)

AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle (216347)

AMOKLAVIN DUO 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle (216347)

DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle (216346)

DEVA-AMOXYCLAV 400/57 amoxicillin 400mg (as trihydrate) and clavulanic acid 57mg (as potassium clavulanate) powder for oral suspension bottle (216346)

News

No news articles found

On this page

Overview
Clinical Trials
Approvals8
News

Back to Organizations